Joseph Scheeren
Director · Barinthus Biotherapeutics plc.
Individual
- 2026
- Sep 9, 2026
- 1
Filings (90d)
Other insiders active in the same sector
No other insider has filed at Joseph Scheeren's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- Robert M. Williams Jr. - $268.34M in AVAH purchases and sales in the last 12 months
- Paul R. Vigano - $268.34M in AVAH purchases and sales in the last 12 months
- A/S Genmab - $234.86M in MRUS purchases and sales in the last 12 months
- Weiss Asset Management LP - $233.35M in AVDL purchases and sales in the last 12 months
- J.H. Whitney Equity Partners VII, LLC - $232.77M in AVAH purchases and sales in the last 12 months
- James Edgemond - $201.52M in UTHR purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Joseph Scheeren?
Joseph Scheeren is a corporate insider, tracked as Director of Barinthus Biotherapeutics plc. (BRNS). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Joseph Scheeren submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
